Pfizer recently announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunised against RSV disease), a phase-III clinical trial evaluating the efficacy, immunogenicity and safety of a single…
Latest News
-
Uncategorized
-
Uncategorized
Express Pharma Granules India gets licence from DRDO to manufacture and market COVID-19 drug 2-DG
Granules India said on Thursday that it has received licence from Defence Research and Development Organisation (DRDO) to manufacture and market COVID-19 treatment drug, 2- Deoxy-D-Glucose (2-DG). Developed by DRDO,…
-
Dr Reddy’s Laboratories yesterday launched Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules in the Canadian market. The product is approved by Health Canada, the company notified in a statement.…
-
Uncategorized
Leaders In The Dental Segment In India, ICPA Aims To Increase Reach In The Overseas Markets Over The Next Decade
ICPA Health Products Ltd (ICPA), India’s leading Pharma Company in the oral healthcare segment has entered its 50th year on the 27th of last month. Founded on 27th August 1972 by Mr Rohit Mehta it’s Managing Director,…
-
Health experts and medical groups are pushing to stamp out the growing use of a decades-old parasite drug to treat COVID-19, warning that it can cause harmful side effects and…
-
University of Colorado Boulder and University of Maryland researchers have found that while playing musical instruments can emit the same levels of potentially COVID-laden airborne particles as singing, simple safety…